
Three times as many manufacturers expect more 3PL use as expect less; 38% see no change
Three times as many manufacturers expect more 3PL use as expect less; 38% see no change
Postponement of public data for six months is justified by slow rollout of CMS rules, they say
MedVantx pursues manufacturers looking for alternative distribution channels
Blackstone Group-owned CDMO nets over $800 million
Battlefield over drug pricing and availability continues to widen between plan managers and pharma
Outsourced contract-administration provider highlights growth in invoicing and financial stewardship burdens
First to gain newly established program reviewing therapy management and chronic care
Amped-up financial transactions continue to roil the industry as Amgen announces a big layoff
Vaccine working group tries to build consensus on temperature control and dispensing practices
Adds drug development services to its clinical, commercial packaging
Rogue online pharmacies are going the brick-and-mortar route
Generics association ramps up criticism of brand owners' tactics to delay generic introductions
US drug-wholesaling leader has 'never had a true 3PL offering'--but that changes now
Latest ZS AccessMonitor asks, 'Who are [physicians] listening to?'
Latest version is 'based on our evolving understanding of the DSCSA'
Dispute continues the ongoing battles between drug distributors and DEA
Siren Interactive hires more executives, moves to downtown Chicago
After patent expiries, 'The industry has turned a corner'
Family of GTS Carry Packs handles drugs that patients self-administer
Speedy delivery to hospitals and clinics is the goal
Cloud-based system automatically collects and analyzes company’s datalogger outputs
Meanwhile, competitor CSafe Global broadens its containers' usability
Pharma distributors and dispensers worry about more opioid abuse
Looking for the 'golden record' of physician demographics
Ongoing brand monitoring needs to be managed more holistically
Deloitte veteran is a board director of the company
The hope is that NABP's oversight will limit illicit online-pharmacy activity
European consumers will eventually have a pan-European method of checking pharmacy legitimacy
Debuted at BIO, Covance's platform will showcase its clients' early-stage drug candidates